Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

About the Company

广州泰诺迪生物科技有限公司是以研发全人源单克隆抗体一类生物新药,并在此基础上开展针对人类重大疾病如肿瘤、自身免疫病及传染病的免疫治疗,以及提供相应的科技服务为主营方向创新型生物科技企业。公司致力于运用*全人源单克隆抗体发现与分离技术,研发具有自主产权的用于治疗和预防传染病、自身免疫性疾病、肿瘤等的一类生物新药,及建立基于DC疫苗、CART技术等用于治疗肿瘤、自身免疫性疾病等的免疫治疗新方法。公司技术平台的建立目标是引领支撑全国的生物医药行业向前发展。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Related Industry Tags

Business Registration

Provided by

Operating Status: 注销
Registered Capital: 299万(元)
Legal Representative: 何有文
Date Established:
Credit Code: 91440101058912766C
Registered Address: 广州市天河区新塘大街3号6栋402房A285(仅限办公)

Partners & Suppliers

艾迪药业与广州泰诺迪签署技术转让合同,获得全人源抗破伤风毒素单克隆抗体TNM002的全球独家权益。 Source
合作客户 技术转让/合作研发

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates